Home LiteratureArticle Details
PMID: 26742586 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation.

Scientific reports ·Vol. 6 ·2016-01-08 ·Pages 19032

Agus A, Denizot J, Thévenot J, Martinez-Medina M, Massier S, Sauvanet P, Bernalier-Donadille A, Denis S, Hofman P, Bonnet R, Billard E, Barnich N

Abstract

Recent advances have shown that the abnormal inflammatory response observed in CD involves an interplay among intestinal microbiota, host genetics and environmental factors. The escalating consumption of fat and sugar in Western countries parallels an increased incidence of CD during the latter 20(th) century. The impact of a HF/HS diet in mice was evaluated for the gut micro-inflammation, intestinal microbiota composition, function and selection of an E. coli population. The HF/HS diet created a specific inflammatory environment in the gut, correlated with intestinal mucosa dysbiosis characterized by an overgrowth of pro-inflammatory Proteobacteria such as E. coli, a decrease in protective bacteria, and a significantly decreased of SCFA concentrations. The expression of GPR43, a SCFA receptor was reduced in mice treated with a HF/HS diet and reduced in CD patients compared with controls. Interestingly, mice treated with an agonist of GPR43 were protected against DSS-induced colitis. Finally, the transplantation of feces from HF/HS treated mice to GF mice increased susceptibility to AIEC infection. Together, our results demonstrate that a Western diet could aggravate the inflammatory process and that the activation of the GPR43 receptor pathway could be used as a new strategy to treat CD patients.

MeSH Terms
Animals Bacterial Adhesion/drug effects Benzeneacetamides/pharmacology Colitis/chemically induced,genetics,microbiology,prevention & control Crohn Disease/etiology,genetics,microbiology,prevention & control Diet, High-Fat/adverse effects Diet, Western/adverse effects Dietary Sucrose/adverse effects Disease Susceptibility Dysbiosis/etiology,genetics,microbiology,prevention & control Escherichia coli/growth & development,metabolism,pathogenicity Fatty Acids, Volatile/metabolism Fecal Microbiota Transplantation Female Gastrointestinal Microbiome/drug effects Gene Expression Regulation Gene-Environment Interaction Humans Intestinal Mucosa/drug effects,microbiology,pathology Male Mice Receptors, G-Protein-Coupled/agonists,genetics,metabolism Sodium Dodecyl Sulfate
Chemicals
Benzeneacetamides Dietary Sucrose Fatty Acids, Volatile Ffar2 protein, mouse Receptors, G-Protein-Coupled Sodium Dodecyl Sulfate
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Agus Allison
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France.
Denizot Jérémy
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France.
Thévenot Jonathan
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France. | Clermont Université, Université d'Auvergne, Centre de Recherche en Nutrition Humaine Auvergne, EA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Clermont-Ferrand, France.
Martinez-Medina Margarita
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France.
Massier Sébastien
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France.
Sauvanet Pierre
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France. | Digestive Surgery Department, Centre Hospitalier Universitaire, Clermont-Ferrand 63000, France.
Bernalier-Donadille Annick
UR454 Microbiology Division, INRA, Research Centre of Clermont-Ferrand-Theix, 63122 Saint Genès-Champanelle, France.
Denis Sylvain
Clermont Université, Université d'Auvergne, Centre de Recherche en Nutrition Humaine Auvergne, EA 4678 CIDAM, Conception Ingénierie et Développement de l'Aliment et du Médicament, Clermont-Ferrand, France.
Hofman Paul
Laboratory of Clinical and Experimental Pathology and Hospital-Related Biobank (BB 0033-00025), Pasteur Hospital, and IRCAN CNRS UMR 7284, Inserm U1081, Nice Sophia Antipolis University, France.
Bonnet Richard
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France. | Bacteriology Department, Centre Hospitalier Universitaire, Clermont-Ferrand 63000, France.
Billard Elisabeth
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France. | Institut Universitaire de Technologie, Génie Biologique, Aubière, France.
Barnich Nicolas
Clermont Université, M2iSH, UMR 1071 INSERM/Université d'Auvergne, Unité Sous Contrat 2018 Institut National de la Recherche Agronomique, Clermont-Ferrand, France. | Institut Universitaire de Technologie, Génie Biologique, Aubière, France.
References (41)
41 references, click to expand
  1. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces.
    Appl Environ Microbiol. 2007 Feb;73(4):1073-8 PMID: 17189447
  2. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease.
    Gut. 2007 May;56(5):669-75 PMID: 17028128
  3. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.
    J Clin Invest. 2007 Jun;117(6):1566-74 PMID: 17525800
  4. Unravelling the pathogenesis of inflammatory bowel disease.
    Nature. 2007 Jul 26;448(7152):427-34 PMID: 17653185
  5. Invasive Escherichia coli are a feature of Crohn's disease.
    Lab Invest. 2007 Oct;87(10):1042-54 PMID: 17660846
  6. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.
    ISME J. 2007 Sep;1(5):403-18 PMID: 18043660
  7. New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations.
    Inflamm Bowel Dis. 2008 May;14(5):709-20 PMID: 18095316
  8. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
    Diabetes. 2008 Jun;57(6):1470-81 PMID: 18305141
  9. Evolution of mammals and their gut microbes.
    Science. 2008 Jun 20;320(5883):1647-51 PMID: 18497261
  10. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease.
    Inflamm Bowel Dis. 2009 Jun;15(6):872-82 PMID: 19235912
  11. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.
    J Exp Med. 2009 Sep 28;206(10):2179-89 PMID: 19737864
  12. High-fat diet determines the composition of the murine gut microbiome independently of obesity.
    Gastroenterology. 2009 Nov;137(5):1716-24.e1-2 PMID: 19706296
  13. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
    Nature. 2009 Oct 29;461(7268):1282-6 PMID: 19865172
  14. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation.
    J Immunol. 2009 Dec 1;183(11):7514-22 PMID: 19917676
  15. Role of diet in the development of inflammatory bowel disease.
    Inflamm Bowel Dis. 2010 Jan;16(1):137-51 PMID: 19462428
  16. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.
    Am J Gastroenterol. 2011 Apr;106(4):563-73 PMID: 21468064
  17. Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch.
    J Nutr. 2011 May;141(5):883-9 PMID: 21430242
  18. Epidemiology and natural history of inflammatory bowel diseases.
    Gastroenterology. 2011 May;140(6):1785-94 PMID: 21530745
  19. Regulation of inflammation by short chain fatty acids.
    Nutrients. 2011 Oct;3(10):858-76 PMID: 22254083
  20. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.
    Inflamm Bowel Dis. 2012 May;18(5):913-24 PMID: 21994005
  21. The gut microbiota in IBD.
    Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):599-608 PMID: 22907164
  22. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice.
    Cell Metab. 2013 Jan 8;17(1):141-52 PMID: 23312289
  23. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.
    Gastroenterology. 2013 Aug;145(2):396-406.e1-10 PMID: 23665276
  24. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
    Science. 2013 Aug 2;341(6145):569-73 PMID: 23828891
  25. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation.
    Gut. 2014 Jan;63(1):116-24 PMID: 23598352
  26. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
    Nature. 2013 Dec 19;504(7480):451-5 PMID: 24226773
  27. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis.
    Nat Med. 2014 Feb;20(2):159-66 PMID: 24390308
  28. Perspectives on the therapeutic potential of short-chain fatty acid receptors.
    BMB Rep. 2014 Mar;47(3):173-8 PMID: 24499669
  29. Diet dominates host genotype in shaping the murine gut microbiota.
    Cell Host Microbe. 2015 Jan 14;17(1):72-84 PMID: 25532804
  30. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease.
    Am J Gastroenterol. 2002 Apr;97(4):939-46 PMID: 12003430
  31. Effects of short-chain fatty acid-supplemented total parenteral nutrition on intestinal pro-inflammatory cytokine abundance.
    Dig Dis Sci. 2002 Sep;47(9):2049-55 PMID: 12353854
  32. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.
    J Biol Chem. 2003 Mar 28;278(13):11312-9 PMID: 12496283
  33. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer.
    Gastroenterology. 2004 Jul;127(1):80-93 PMID: 15236175
  34. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.
    Gastroenterology. 2004 Aug;127(2):412-21 PMID: 15300573
  35. Differential carbohydrate media and anaerobic replica plating techniques in delineating carbohydrate-utilizing subgroups in rumen bacterial populations.
    Appl Environ Microbiol. 1980 Apr;39(4):709-19 PMID: 6769390
  36. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.
    Gastroenterology. 1998 Dec;115(6):1405-13 PMID: 9834268
  37. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease.
    Infect Immun. 1999 Sep;67(9):4499-509 PMID: 10456892
  38. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.
    Aliment Pharmacol Ther. 2006 Oct;24 Suppl 3:11-8 PMID: 16961738
  39. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
    Gut. 2006 Dec;55(12):1760-7 PMID: 16648155
  40. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production.
    FASEB J. 2000 Dec;14(15):2380-2 PMID: 11024006
  41. Mucosal flora in inflammatory bowel disease.
    Gastroenterology. 2002 Jan;122(1):44-54 PMID: 11781279
Article Info
Journal
Scientific reports
Abbr.
Sci Rep
ISSN
2045-2322
Published
2016-01-08
Epub
2016-00-08
Pages
19032
Language
English
Region
England
NLM ID
101563288
PMCID
PMC4705701
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com